These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37243031)

  • 61. Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs.
    Twitchell EL; Tin C; Wen K; Zhang H; Becker-Dreps S; Azcarate-Peril MA; Vilchez S; Li G; Ramesh A; Weiss M; Lei S; Bui T; Yang X; Schultz-Cherry S; Yuan L
    Gut Pathog; 2016; 8():51. PubMed ID: 27826359
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants.
    Cohet C; Cheuvart B; Moerman L; Bi D; Caplanusi A; Kariyappa M; Lalwani S; Mitra M; Sapru A; Saha S; Varughese PV; Kompithra RZ; Gandhi S
    Hum Vaccin Immunother; 2021 Nov; 17(11):4646-4653. PubMed ID: 34428112
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.
    Azevedo MP; Vlasova AN; Saif LJ
    Expert Rev Vaccines; 2013 Feb; 12(2):169-81. PubMed ID: 23414408
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
    Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
    Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of rotavirus NSP4 protein on the immune response and protection of the S
    Liu C; Huang P; Zhao D; Xia M; Zhong W; Jiang X; Tan M
    Vaccine; 2021 Jan; 39(2):263-271. PubMed ID: 33309483
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
    Hewitt JS; Karuppannan AK; Tan S; Gauger P; Halbur PG; Gerber PF; De Groot AS; Moise L; Opriessnig T
    Vaccine; 2019 Jul; 37(31):4302-4309. PubMed ID: 31248687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
    Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.
    Yuan L; Wen K; Azevedo MS; Gonzalez AM; Zhang W; Saif LJ
    Vaccine; 2008 Jun; 26(26):3322-31. PubMed ID: 18456375
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial.
    Fellows T; Page N; Fix A; Flores J; Cryz S; McNeal M; Iturriza-Gomara M; Groome MJ
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766217
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs.
    Zhang W; Azevedo MS; Wen K; Gonzalez A; Saif LJ; Li G; Yousef AE; Yuan L
    Vaccine; 2008 Jul; 26(29-30):3655-61. PubMed ID: 18524434
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel simian adenovirus-vectored COVID-19 vaccine elicits effective mucosal and systemic immunity in mice by intranasal and intramuscular vaccination regimens.
    Zhang P; Luo S; Zou P; Deng Q; Wang C; Li J; Cai P; Zhang L; Li C; Li T
    Microbiol Spectr; 2023 Dec; 11(6):e0179423. PubMed ID: 37877750
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children.
    Lee B; Colgate ER; Carmolli M; Dickson DM; Gullickson S; Diehl SA; Ara R; Alam M; Kibria G; Abdul Kader M; Afreen S; Ferdous T; Haque R; Kirkpatrick BD
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):127-133. PubMed ID: 34904667
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.
    Vega CG; Bok M; Vlasova AN; Chattha KS; Gómez-Sebastián S; Nuñez C; Alvarado C; Lasa R; Escribano JM; Garaicoechea LL; Fernandez F; Bok K; Wigdorovitz A; Saif LJ; Parreño V
    PLoS Pathog; 2013; 9(5):e1003334. PubMed ID: 23658521
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus.
    Pan Y; Jia R; Li J; Wang M; Chen S; Liu M; Zhu D; Zhao X; Wu Y; Yang Q; Yin Z; Jing B; Huang J; Zhang S; Zhang L; Liu Y; Yu Y; Tian B; Pan L; Rehman MU; Cheng A
    Virol J; 2020 May; 17(1):67. PubMed ID: 32398028
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus.
    Azevedo MS; Yuan L; Pouly S; Gonzales AM; Jeong KI; Nguyen TV; Saif LJ
    J Virol; 2006 Jan; 80(1):372-82. PubMed ID: 16352562
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model.
    Vlasova AN; Chattha KS; Kandasamy S; Siegismund CS; Saif LJ
    J Immunol; 2013 May; 190(9):4742-53. PubMed ID: 23536630
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of a live attenuated trivalent porcine rotavirus A vaccine against disease caused by recent strains most prevalent in South Korea.
    Park JG; Alfajaro MM; Cho EH; Kim JY; Soliman M; Baek YB; Park CH; Lee JH; Son KY; Cho KO; Kang MI
    Vet Res; 2019 Jan; 50(1):2. PubMed ID: 30616694
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.
    Wen X; Cao D; Jones RW; Li J; Szu S; Hoshino Y
    Vaccine; 2012 Sep; 30(43):6121-6. PubMed ID: 22885016
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
    Kazimbaya KM; Chisenga CC; Simuyandi M; Phiri CM; Laban NM; Bosomprah S; Permar SR; Munsaka S; Chilengi R
    PLoS One; 2020; 15(11):e0240714. PubMed ID: 33170860
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of maternal antibodies on protection and development of antibody responses to human rotavirus in gnotobiotic pigs.
    Hodgins DC; Kang SY; deArriba L; Parreño V; Ward LA; Yuan L; To T; Saif LJ
    J Virol; 1999 Jan; 73(1):186-97. PubMed ID: 9847321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.